HCA Healthcare, Inc. (NYSE:HCA) Position Reduced by Kentucky Retirement Systems

Kentucky Retirement Systems decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 11.4% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 12,945 shares of the company’s stock after selling 1,660 shares during the period. Kentucky Retirement Systems’ holdings in HCA Healthcare were worth $5,261,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Acadian Asset Management LLC lifted its stake in HCA Healthcare by 115.5% during the first quarter. Acadian Asset Management LLC now owns 3,372 shares of the company’s stock valued at $1,123,000 after purchasing an additional 1,807 shares during the last quarter. Allstate Corp acquired a new position in shares of HCA Healthcare in the 1st quarter worth $212,000. Cynosure Group LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at $320,000. PAX Financial Group LLC acquired a new stake in HCA Healthcare during the 1st quarter worth about $202,000. Finally, UniSuper Management Pty Ltd boosted its holdings in shares of HCA Healthcare by 8.0% in the first quarter. UniSuper Management Pty Ltd now owns 50,788 shares of the company’s stock worth $16,939,000 after buying an additional 3,752 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the topic of a number of research reports. Truist Financial upped their target price on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Leerink Partners lifted their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Royal Bank of Canada raised their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, KeyCorp cut their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Stock Down 0.7 %

Shares of HCA opened at $342.96 on Friday. HCA Healthcare, Inc. has a 52 week low of $238.82 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a market capitalization of $86.87 billion, a P/E ratio of 15.40, a P/E/G ratio of 1.34 and a beta of 1.68. The company has a 50-day simple moving average of $385.11 and a 200-day simple moving average of $357.58.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare’s payout ratio is 11.85%.

Insider Buying and Selling at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 21.97 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 in the last 90 days. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.